DESERIEE STOFFERAHN: Open Payments
NPI 1457003139 · ROCK SPRINGS, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 18 payments from 11 companies in 2025. Trend: 2023 $264 · 2024 $76 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $74 |
| Lilly USA, LLC | 3 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Viatris Specialty LLC | 1 | $27 |
| Dexcom, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| Amgen Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, REXULTI, MOUNJARO, YUPELRI, Dexcom G6 Transmitter, NURTEC ODT, CAPVAXIVE, ZAVZPRET.
Industry payments across WY — which companies pay providers there.
